% | $
Quotes you view appear here for quick access.

MiMedx Group, Inc. Message Board

cimcbride 61 posts  |  Last Activity: Jul 11, 2016 4:16 PM Member since: Aug 5, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to


    by mrmarket2000 Jul 10, 2016 12:57 PM
    cimcbride cimcbride Jul 11, 2016 4:16 PM Flag

    Counting on it too as I am starting to nibble. And I do mean nibble.

  • Reply to

    Minnesota Farmer is a loser

    by ganggreen77 Jun 30, 2016 3:34 PM
    cimcbride cimcbride Jun 30, 2016 10:25 PM Flag

    Have lots of my eggs in AVXL. Greater than 100k shares. A highly likely remedy for Alzheimer's is no mere improved band aid. If this is for real and it seems to be this will set the world on fire. Magnitude being that of a cure for cancer. All cancer.

    Understated but got you're attention.

  • cimcbride cimcbride Jun 24, 2016 2:39 PM Flag

    Perhaps the VA performed a retrospective study of Grafix v Epifix

    I've heard that it is fashionable to do so and could save money and heartache. And limbs too.

  • cimcbride cimcbride Jun 24, 2016 9:26 AM Flag

    Sued for publishing a retrospective study.

    Really...what's wrong with that?? As a physician if I reviewed results from two alternative treatments over a specified period (time acting as the significant variable) and concluded that one treatment was vastly superior to another and altered my future behavior accordingly.......I should be sued and censured?? Really??

    True only if I decided to proceed using the inferior treatment. MiMedx suit is laughable and petty and this will be readily apparent to the courts

    And to physicians.

    And a conspiracy to boot but failing to sue the co-conspirator...Dr Johnson. You're kidding, right?

    Don't confuse management sins with product inferiority. Grafix is superior by magnitudes and MiMedx just called further attention to it. We can act so foolishly when annoyed...and the truth can be exceedingly annoying.


  • Reply to

    Board Under Siege

    by cliftonpoint Jun 23, 2016 12:09 PM
    cimcbride cimcbride Jun 23, 2016 4:17 PM Flag

    Low float, very low market cap (laughable really), high short interest and little or no movement on fabulous news. Many, many many companies could benefit from their tech and patients too. Targets, with great specificity, malignant cells and facilitates therapeutic drug (or radioactive isotope) movement across the cell membrane.

    Haven't studied this in great detail yet but if accurate the ramifications are, how can I say, otherworldly. More effective chemo and less toxicity to normal cells.

    Disclosure: I own 9500 shares and have an MD degree.

    Can this be a $20m company for long?? Only if shorts know a lot more than I do or have a death wish.

  • Reply to

    One Lucky Fella

    by finn.joseph Jun 17, 2016 7:35 AM
    cimcbride cimcbride Jun 17, 2016 8:04 AM Flag

    Sorry fat fingers on iPhone gave a thumbs down.

    Truly Anavex could be the most important pharmacological discovery ever, or certainly of our lifetimes.

  • Reply to

    Hanging onto $5

    by minnesotafarmcountry Jun 10, 2016 10:14 AM
    cimcbride cimcbride Jun 10, 2016 4:29 PM Flag

    I don't know....there is sure an abundance of crazy to go around.

    Never thought that the company of SO boring Randy and Peter (and even friend Mesoblast) would ever have so many bunnies coming out the hat. The trick is getting old.

    Probably the buying opportunity of a lifetime once the magic show ends. Big question is ...when does it end?

    A buyback would be heroic or even NEV increasing its stake.

    I'm available for CEO.

  • cimcbride cimcbride May 2, 2016 8:52 AM Flag

    Very impressive data. Very.

    This will get Grafix in the door where Epifix is now being used exclusively. If this can be reaffirmed it will lead to the death of Epifix as a "viable" competitive skin substitute.

  • Reply to

    Settlement Conference?

    by johnces1313 Apr 21, 2016 8:20 AM
    cimcbride cimcbride Apr 21, 2016 5:54 PM Flag

    NOW must be less anxiety provoking than LATER which means $$$$. Maybe they feel vulnerable on the patent front...the ones they don't control...which may be all of them. Opposite of J&J usual stall tactics if I'm reading this right. Feels like a game of though. Is DECN inclined to settle and get on with it? Like my licensing scenario but we each and all tend to favor our own scripts.

    Pardon if possible my still being at the tea leaf stage.

    Lot to be learned here. And now with ctixers we have added a dash of flamboyance and virgin lawyerly perspective.

  • cimcbride cimcbride Apr 20, 2016 11:59 PM Flag

    Afraid your response misses the point by a mile.

    DECN's strip competes with J&J. If J&J cares to remain in this lucrative segment they have to smoke the peace pipe i.e. make a deal with DECN. So what does the deal cost...well at 10cents of a $1.25 strip these are the numbers. more or less.So my conclusion is that there is compelling upside. So $1,2,3...etc

    If you want to participate you have to buy stock.

  • cimcbride cimcbride Apr 5, 2016 12:37 PM Flag

    Quite thin actually. And painfully honest. Had a good mother.....
    And 2.2m shares is a closer estimate.
    And do you want to lose an easy $10k. Bet me and we'll place our money with an independent party of your choosing who will decide who gets the checks.
    Won't take me up. Then forever be known as a blowh*rd.....but the consolation: $10k richer.
    Ready BLOWH*ARD. Your move.

  • cimcbride cimcbride Apr 5, 2016 11:29 AM Flag

    Am I still a newbie? Been here since last Nov. Own more than 2m shares.

    Newbie or drippin' with formalin, when I leave likely you and the serfs will know it. Be like a crop failure.(Maybe an exaggeration).

  • cimcbride cimcbride Apr 5, 2016 9:19 AM Flag

    And yes I have two #$%$ an inside joke with friends.

  • cimcbride cimcbride Apr 5, 2016 9:16 AM Flag

    Another post, more drivel. Brief thankfully.

    Await that one in ten, or was I being too flippin" generous.

  • Reply to

    can't file 10k in the late filing grace period

    by yappy_mutt Mar 15, 2016 4:39 PM
    cimcbride cimcbride Mar 15, 2016 9:34 PM Flag

    I'm torn. Usually delisting issues are related to a lack of money but Osiris has plenty and that is a good thing. So let's get the accounting hit over and get on with running the business and in a year all (or most) will be forgiven. Some funds will sell as the stock will be under $5 and some can't/won't hold a stock that is late with financials. Also the legal predators will be circling and issuing pr's dissuading potential new investors. Yes the making of a pariah.

    Best might be to sell and by back in a month or more to qualify for the tax loss. This bargain should last for awhile.

    Thankfully the shorts will be keeping the price up as they cover.

    Reading this one can tell that I'm indeed torn. (And of course I bought another 2k today putting my mouth where my money used to be).

    Hard to believe that this happened with Friedli on duty.

  • Forbes

    Topic: Non approved uses of regulated drugs etc.

    FDA buckles under 1st Amendment
    Ramifications for Osiris for example Grafix and VLUs (venous leg ulcers) etc etc etc.
    Also Mesobast and indications for Prochymal.

    This is VERY BIG for patients and pharma.

  • Reply to


    by frasoda80 Mar 12, 2016 10:10 AM
    cimcbride cimcbride Mar 12, 2016 2:41 PM Flag

    Dividend..who knows but in retrospect sure was a curious decision. Won't attempt to answer your other concerns. Just ask yourself the company more valuable now than the last time it was (a beaten down) $5 in late 2012 when Sanofi bailed.... when it had the $$$$ sinkhole Prochymial and no Grafix, no Cartiform, no BIO4, no insurance coverage, no new products (for 2016/17 Ozark can recite those), no partnerships with Stryker and Arthrex, no imminent royalties from Mesoblast, no BLA cooking....
    BLA, BLA, BLA......not the usual bla, bla, bla that we've grown accustom to.
    Soo (for you Randy) get the value picture? Soo with no Prochymal to sell (our anchor at that time) we have unloaded Lode in lieu. Now Lode struck me a a competent/no nonsense guy but his explanation of the accounting dilemma which became a fiasco must not have charmed Friedl....soo it seems.

    So here we are again at $5. No new debt or shares to be issued.

    Seems a good place to buy.

  • Reply to


    by frasoda80 Mar 12, 2016 10:10 AM
    cimcbride cimcbride Mar 12, 2016 2:03 PM Flag

    Private unlikely. Friedli's buddies in NEV would be annoyed I imagine. They probably are already up in arms over the share price so best action is to get the share price up.
    The revised accounting is what Wall St is waiting for to start buying again. Most if not all of the selling pressure should be over. Now center stage will be bargain hunters and shorts covering as they have made a nice profit and will fear overstaying their welcome.
    And if it falls another $1 I'll buy another 10k.
    Good time to announce a 1m share buyback to relight the fire.

  • Reply to


    by frasoda80 Mar 12, 2016 10:10 AM
    cimcbride cimcbride Mar 12, 2016 1:19 PM Flag

    Disaster is yesterday's news. Way oversold and beneath lower Bollinger Band. Good products with revenues to increase substantially over next few quarters/years. Substantial cash on hand. House cleaning over or nearly so.
    Downside risk $4.50. Upside one helluva lot.

    Bought 11k shares this week.

  • Reply to

    Summary Judgement denied

    by mattchad21 Mar 8, 2016 9:06 PM
    cimcbride cimcbride Mar 11, 2016 9:28 AM Flag

    Ever consider yourself to be the Tooth Fairy?

    I have one tooth that could be available Sunday evening. No disillusionments I trust. I'll sleep week on it.

    Thanks Tooth Fairy.

8.65-0.28(-3.14%)4:00 PMEDT